Topical Testosterone Formulations And Associated Methods

Abstract

A topical testosterone formulation is disclosed. In one aspect, the formulation may include a therapeutically effective amount of micronized testosterone, an arginine ingredient, and a tocopherol ingredient admixed with a poloxamer lecithin organogel. Additional ingredients may be included, such as melatonin, oxytocin, DHEA, and progesterone.


Claims
Owners (US)

Information currently unavailable.

CPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jun 1, 2004
  • Application: Dec 11, 2001
    US US 2156401 A
  • Priority: Dec 11, 2001
    US US 2156401 A
  • Priority: Dec 11, 2000
    US US 25471300 P

Download Citation


Sign in to the Lens

Feedback